Natural Killer Cells Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapeutics (Natural killer Cell Therapies, Natural killer Cell Directed Antibodies); Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others); End User (Research Centers and Institutes, Hospitals, Others) and Geography
Report Code: TIPRE00015768 No. of Pages: 150 Category: Healthcare IT Status: Upcoming
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW
Natural killer cells are large granular lymphocytes that respond quickly to a pathological challenge. In addition, they are responsible for producing immunoregulatory cytokines. Moreover, they act as an important component of the innate immune system of a human. The key role of NK cells is to generate an immune response against malignancies and viral infections.
MARKET SCOPE
The "Global Natural killer cells therapeutics Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Natural killer cells therapeutics market with detailed market segmentation by therapeutics, application, end user and geography. The report provides key statistics on the market status of the leading Natural killer cells therapeutics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
MARKET DYNAMICS
Drivers:
Restraints:
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Natural killer cells therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Natural killer cells therapeutics market in these regions.
IMPACT OF COVID-19 ON NATURAL KILLER CELLS THERAPEUTICSMARKET
The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt and will significantly affect the natural killer cell therapeutics market in 2020. COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all outdoor events restricted; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. All these factors will restrict the growth of the market due to pandemic.
The report covers key developments in the natural killer cells therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Natural killer cells therapeuticsmarket are anticipated to lucrative growth opportunities in the future with the rising demand for Natural killer cells therapeutics in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Natural killer cells therapeutics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
Natural killer cells are large granular lymphocytes that respond quickly to a pathological challenge. In addition, they are responsible for producing immunoregulatory cytokines. Moreover, they act as an important component of the innate immune system of a human. The key role of NK cells is to generate an immune response against malignancies and viral infections.
MARKET SCOPE
The "Global Natural killer cells therapeutics Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Natural killer cells therapeutics market with detailed market segmentation by therapeutics, application, end user and geography. The report provides key statistics on the market status of the leading Natural killer cells therapeutics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on therapeutics, the global Natural killer cells therapeutics market is segmented into NK Cell Therapies, NK Cell Directed Antibodies.
- Based on application, the market is categorised into Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others.
- Based on end user, the market is categorised into Research Centers and Institutes , Hospitals, Others.
MARKET DYNAMICS
Drivers:
- Rise in adoption of NK cells for the treatment of cancer, infections, and liver diseases.
- The rise in awareness among the population regarding various immunotherapies
- increase in R&D for the development of bi-specific antibody for engaging NK cells
Restraints:
- The lack of specificity and poor in-vivo survival of the cells limit the natural killer cells therapeutics.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Natural killer cells therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Natural killer cells therapeutics market in these regions.
IMPACT OF COVID-19 ON NATURAL KILLER CELLS THERAPEUTICSMARKET
The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt and will significantly affect the natural killer cell therapeutics market in 2020. COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all outdoor events restricted; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. All these factors will restrict the growth of the market due to pandemic.
The report covers key developments in the natural killer cells therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Natural killer cells therapeuticsmarket are anticipated to lucrative growth opportunities in the future with the rising demand for Natural killer cells therapeutics in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Natural killer cells therapeutics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Affimed N.V.
- Celgene Corporation
- Fate Therapeutics
- Fortress Biotech
- Glycostem Therapeutics BV
- Innate Pharma S.A.
- Nantkwest Inc.
- Nkarta Therapeutics, Inc.
- EMERcell
- Ziopharm Oncology Inc.